Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
Status:
Terminated
Trial end date:
2014-04-16
Target enrollment:
Participant gender:
Summary
This is a study about the efficiency and safety of a 1mg+1mg hydromorphone pain management
protocol for the treatment of moderate to sever pain in the Emergency Department. Appropriate
patients 60 years and older who present with a condition that causes moderate to severe pain,
according to the attending physician's judgment, in which the physician would order the use
of parenteral analgesia will be enrolled in one of two study arms, "1+1" versus usual care
group. 1+1 patients will receive 1mg hydromorphone followed by another 1mg after 15 minutes
if pain persists. Usual care group patients will have pain treated per the discretion of the
attending physician. Respiratory status, vital signs, and pain scores will be monitor to
assess the efficiency of pain control as well as the safety of pain medicine administration
in terms of respiratory depression.